| Literature DB >> 28450199 |
Ruxandra Calin1, Eric Caumes2, Florence Reibel3, Anzime Ali Mohamed2, Florence Brossier3, Violaine Foltz4, Samia Boussouar5, Bruno Fautrel4, Max Maurin6, Christine Katlama2, Valérie Pourcher2.
Abstract
A case of severe glandular tularemia in a patient receiving anti-tumour necrosis factor (TNF) therapy is reported here. The patient required prolonged treatment with doxycycline-ciprofloxacin due to early relapse after ciprofloxacin was stopped. Tularemia may have a more severe course in patients receiving anti-TNF. This may thus be an indication for more aggressive treatment.Entities:
Keywords: Anti-TNF therapy; Certolizumab; Psoriatic arthritis; Tularemia
Mesh：
Substances：
Year: 2017 PMID： 28450199 DOI： 10.1016/j.ijid.2017.04.014
Source DB: PubMed Journal: Int J Infect Dis ISSN： 1201-9712 Impact factor: 3.623